imaradenant



imaradenant


SMILES Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1
InChIKey NCWQLHHDGDXIJN-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Molecular weight (Da) 315.1

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

No bioactivity data available.

imaradenant


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

Compound is not listed as a drug.